Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis

The efficacy of cannabinoids in the treatment of multiple sclerosis is widely documented; however their use is limited by psychoactivity mainly ascribed to the activation of the cannabinoid receptor CB1. Emerging findings support as alternative strategy in the treatment of neurodegenerative disorder...

Descripción completa

Detalles Bibliográficos
Autores principales: Malfitano, Anna Maria, Laezza, Chiara, D’Alessandro, Alba, Procaccini, Claudio, Saccomanni, Giuseppe, Tuccinardi, Tiziano, Manera, Clementina, Macchia, Marco, Matarese, Giuseppe, Gazzerro, Patrizia, Bifulco, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641032/
https://www.ncbi.nlm.nih.gov/pubmed/23658734
http://dx.doi.org/10.1371/journal.pone.0062511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641032/
https://www.ncbi.nlm.nih.gov/pubmed/23658734
http://dx.doi.org/10.1371/journal.pone.0062511

Ejemplares similares